Identification of optimal complex adjuvant and bovine ephemeral fever (BEF) antigen combination to elicit potent, protective, and long lasting immunity has been a major challenge for improvement of the vaccines potency against bovine ephemeral fever virus. In this study, three different concentrations (0.1, 0.2 and 0.5%) of a cross-linked polyanionic carbopol combined with a constant concentration (0.2 µg /ml) of saponin were used as solvents for the freeze dried BEF vaccine.
has not been identified, prevention efforts are mainly aimed at efficient vaccination of susceptible animals (4).
The goal of vaccination is to stimulate a strong, protective and long-lasting immune response to the administered antigen. For the achievement of these objectives; potent adjuvant and novel vaccine strategies are required to make the vaccine sufficiently immunogenic to initiate a potent immune response (5&6). Vaccines can be made more efficacious by including an appropriate adjuvant in the composition. Adjuvants are used to accomplish two objectives; they slow the release of antigens from the injection site, and they stimulate the immune system. The use of a polymer of acrylic acid cross-linked with various polyol compounds as an adjuvant is described in U.S. Such polymers are commercially available under the trademark "Carbopol" It is believed that Carbopol behaves in a manner similar to other gels such as collagen and aluminum hydroxide; the active agent is adsorbed on the polymer and the combination is retained at the injection site. The polymer is only slowly dispersed and the active agent is retained at the site for prolonged slow release (7).
Saponins have been widely used as adjuvants for many years and have been included in several veterinary vaccines. On the other hand, the adjuvants have the ability to modulate the cell mediated immune system as well as to enhance antibody production (8). It induces a strong adjuvant effect to T-dependent as well as T-independent antigens. Also it induces production of cytokines such as interleukins and interferon that might mediate their immune stimulant effects (9& 10).
The goal of the present study was to exploit the polyanionic and cross-linked nature Carbopol for a "controlled release" of the BEF antigen. It is also wished to determine if, 
MATERIAL AND METHODS 1-BEF virus strain:
It was isolated from Toukh Tambasha, Monofia Governorate, Egypt during an outbreak in summer 2000 (11&12). This isolate designed as Abbasia virus strain (BEF/AVS/2000) was supplied by the department of Pet Animal Vaccine Research (DPAVR), Veterinary Serum and Vaccine Research Institute, Abbasia, Cairo, Egypt and used as the seed for vaccine preparation after its adaptation to tissue culture.
2-BEF vaccine:
The vaccine was prepared in freeze-dried form (13) and supplied by the department of Pet Animal Vaccine Research, Veterinary Serum and Vaccine Research Institute Abbasia, Cairo.
3-Cell culture:
Baby hamster kidney cell line (BHK-21) was used for virus and titration by SNT (14). It was supplied by the Pet Animal Vaccine Research Dept. Veterinary Serum and Vaccine Research Institute; Abbasia, Cairo.
4-Preparation of adjuvants: 4.1-Saponin:
It was supplied under the cat. No.16109; lot. 71500 by Sigma-Aldrish Labochemikalien Gm6H; Germany. It was prepared as watery solution in a concentration of 0.2 μg /ml in phosphate buffered saline (PBS) (15), and was used as a diluent to inactivate the live attenuate BEF virus vaccine at the time of vaccination and injected directly after reconstitution. 4.2-Carbopol:
It was supplied by Lubrizol as powder. It was dissolved in hot water to prepare three different concentrations (0.2, 0.4 and 1%) of aqueous stock solutions (7). The prepared solutions were subjected to heat sterilization by autoclaving at 121°C for 20 min, then storaged at 4°C until further use.
4.3-Preparation of complexes mixture (saponin-carbopol) adjuvant:
A 1:1 (v/v) of different concentrations of carbopol solution as mentioned with a solution of 0.2 µg/ml saponin was mixed to be obtained three concentrations (0.1, 0.2 and 0.5%) of complexes mixture finally, and then neutralization with 20% Sodium hydroxide to permit them to be readily to dissolve the freeze-dried vaccine.
5-Quality control of the prepared adjuvants:
Sterility, safety and potency were evaluated for the prepared adjuvants (16).
6-Animals:
Eighteen healthy, non-vaccinated beef calves, approximately 12 to 18 months of age were tested and confirmed to be negative to BEF antibodies as screened by SNT. They were divided into six groups, each group contained three animals. Each one of the first three groups was vaccinated with two doses of freeze-dried BEF vaccine reconstituted in one of the different preparations of complexes adjuvant as follow:(0.1% of carpobol plus 0.2 μg /ml of saponin) for 1 st group, (0.2% of carpobol plus 0.2 μg /ml of saponin) for 2 nd group and (0.5% of carpobol plus 0.2 μg /ml of saponin) for 3 rd group. In all cases the used inoculated a dose was 2ml with two weeks interval. The fourth group was vaccinated with two doses of the freeze-dried vaccine reconstituted in saponin of a conc. inoculated with (0.5%/animal) and kept under daily clinical observation for 10 days post inoculation for detection of any abnormalities. Also daily rectal temperature could be recorded and daily clinical examination could be detected. All animals were kept under hygienic measures receiving balanced ration and adequate water and subjected to daily clinical examinations.
7-Sampling:
Serum samples were collected from all animals from the first week post vaccination till the 40 th week for evaluation of the induced neutralizing BEF antibodies.
8-Serum neutralization test (SNT):
It was performed using the micro-technique to detect neutralizing antibodies against BEF virus. The antibody titer was estimated as the final serum dilution Log 2 (17).
9-Enzyme Linked Immunosorbent Assay ( Indirect ELISA):
BEF antigen was prepared from infected BHK 21 cells and concentrated by PEG (6000) MOL. Wet (18), then, used in ELISA to estimate the specific antibodies of BEF virus (19).
RESULTS AND DISCUSSION
Bovine ephemeral fever is an infectious but preventable disease. Primary vaccination in calves followed by regular boosts with quality vaccine usually provides satisfactory protection particularly in countries where the disease is endemic. Appropriate adjuvant selection may be essential to optimize the potency and to tailor the immune response of quality vaccines.
So, this study deals with comparative evaluation of humeral immune response of cattle vaccinated with BEF vaccines with two types of adjuvant "saponin with different concentrations of carbopol". The freeze-dried BEF vaccine showed that they are sterile and safe. Carbopol-based adjuvant suspensions have been used in veterinary vaccines since the 1970's. They have been demonstrated to be safe and effective when used in all animal species (7). The result of sterility test ‫الثاني‬ ‫اجمللد‬ ‫الزراعية‬ ‫للعلوم‬ ‫العربية‬ ‫اجمللة‬ -( ‫العدد‬ 4 ‫أكتوبر‬ ) 9102 applied on the prepared adjuvants showed that they are sterile as they are free from aerobic and anaerobic bacteria and fungi.
From the results shown in table (1), it is clear that the first three groups of calves vaccinated with two doses of freezedried BEF vaccine reconstituted in complexes solvent, the BEF serum neutralizing antibody titers exhibited protective neutralizing BEF antibody titer (1.2 Log 2 ) (13) started from 2 nd wpv (1.3,1.54 and 1.43)and reached the highest titer at 12 th WPV (2.75, 3.12) in the 1 st and 2 nd groups respectively, while in 3 rd group (3.14) at 16 th wpv than persisted in protective titer till 32 nd wpv (1.21) in the 1 st group and at 40 th wpv (1.40 and 1.42) in the 2 nd and 3 rd groups respectively. The vaccinated calves in the fourth group showed that protective neutralizing serum antibody titer (1.42) started from 3 rd wpv, reached highest titer at 12 th wpv (2.68) and persisted in protective titer till 28 th wpv (1.37).
On the other hand, the ELISA results in the table (2) showed that positive serum antibody level (O.D) started from 2 nd WPV (1.6031), reached highest level (O.D) (3.0487) at 12 th WPV in 1 st group and at 16 th wpv in both 2 nd and 3 rd groups (3.3426 and 3.5026 respectively ), persisted positive till 40 th WPV. While the fourth group, showed that positive serum antibody level (O.D) started from 2 nd WPV (1.4236), reached highest level (2.9432) at 12 th WPV, and then dropped after 32 th wpv. These results were shown in comparison to that of the calves kept as non-vaccinated (fifth group) that gave negative results.
All vaccinated groups showed protective level of antibodies near the second and third week post vaccination as saponin based adjuvants have the ability to stimulate the cell mediated immune system as well as to enhance antibody production and have the advantage that only a low dose is needed for adjuvant activity (8). Saponins induce a strong adjuvant effect to T-dependent as well as T-independent antigens. Saponin not only has stimulatory effects on the components of specific immunity, but also presents some nonspecific immune reactions such as inflammation (20&21) and monocyte proliferation (22&23). Observation of a rise in antibody titer following immunization with the dried freezed vaccine dissolve in complexes adjuvant "saponin plus Carbopol" as in the first three groups of calves and longer lasting immunity than in the fourth group. This observation is attributed to a combined effect of direct B-cell activation and antigen delivery by the anionic polymer coupled with saponin ability to enhance antibody responsiveness (24). Carbopol administration triggered rapid and robust leukocyte recruitment, pro-inflammatory cytokine secretion and antigen capture largely by inflammatory monocytes. This indicates that Carbopol has immunostimulatory effects in addition to direct B-cell activation, possibly serving as an antigen delivery system (25&26). The immune-modulating activities of polyanions were first described over 30 years ago (27&28) and more recently, polyacrylicacid polymers termed carbomers have been evaluated as adjuvants in veterinary vaccines (29&30). These carbomers are not harmful in mammals and are more effective than antigen alone. Carbopols have been combined with other adjuvant formulations such as MF59 to yield additive or potentially synergistic adaptive immune responses (31&32).
Concerning the concentration of carbopol used, it was found the highest antibody level obtained with the concentration of 0.5 then 0.2 %, where the concentration of 0.1% showed less result compared with the higher concentration. This result agrees with the disclosure in U.S. Pat. No. 3, 178,350, mixtures of Carbopol 934 with various virus vaccines, resulted in greatly enhanced antibody production in the host when the Carbopols were in the range of 0.25 to 0.50% of the mixture (7).
‫الثاني‬ ‫اجمللد‬
Considering the neutralizing antibody responses, it was clear that BEF adjuvanted with 0.5% Carbopol plus 0.2 µg /ml saponin elicited better humoral response than adjuvanted with saponin alone. 
